RANI THERAPEUTICS HOLDINGS-A (RANI) Stock Balance Sheet
NASDAQ:RANI • US7530181004
Current stock price
1.14 USD
+0.01 (+0.88%)
At close:
1.15 USD
+0.01 (+0.88%)
Pre-Market:
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 4.14M | 3.76M | 5.86M | 27.00M | 117.50M | |||
| Marketable Securities | 0.00 | 23.88M | 42.67M | 71.50M | N/A | |||
| Receivables | 0.00 | 428.00K | N/A | N/A | N/A | |||
| Other Current Assets | 811.00K | 1.68M | 2.31M | 2.40M | 2.10M | |||
| Total Current Assets | 4.96M | 29.74M | 50.85M | 100.90M | 119.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.94M | 6.64M | 6.82M | 7.10M | 4.60M | |||
| Other Non-Current Assets | 245.00K | 246.00K | 246.00K | N/A | N/A | |||
| Total Non-Current Assets | 5.18M | 6.89M | 7.07M | 7.10M | 4.60M | |||
| TOTAL ASSETS | 10.14M | 36.63M | 57.92M | 108.00M | 124.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 13.54M | 15.00M | 4.90M | N/A | 0.00 | |||
| Accrued Expenses | 3.01M | 3.25M | 2.39M | 3.30M | 1.40M | |||
| Accounts Payable | 2.47M | 1.36M | 648.00K | 1.50M | 1.10M | |||
| Other Current Liabilities | 133.00K | 283.00K | 52.00K | 100.00K | 100.00K | |||
| Total Current Liabilities | 19.14M | 19.89M | 7.99M | 4.80M | 2.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 9.61M | 24.48M | 29.10M | 0.00 | |||
| Other Non-Current Liabilities | 2.97M | 3.64M | 0.00 | 100.00K | 0.00 | |||
| Total Non-Current Liabilities | -1.15M | 14.75M | 37.06M | 66.40M | 74.20M | |||
| TOTAL LIABILITIES | 18.00M | 34.64M | 45.05M | 71.20M | 76.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -122.28M | -102.91M | -72.89M | -38.90M | -8.30M | |||
| Additional Paid In Capital | 114.41M | 104.89M | 85.76M | 75.80M | 55.70M | |||
| Minority Interest | -4.11M | 1.50M | 12.58M | 37.10M | 74.20M | |||
| Common Shares | 6.00K | 5.00K | 5.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 3.00K | 5.00K | -12.00K | -100.00K | N/A | |||
| Shares Outstanding | 71.91M | 57.40M | 47.15M | 49.40M | 49.00M | |||
| Tangible Book Value per Share | -0.11 | 0.03 | 0.27 | 0.75 | 0.97 | |||
| Total Shareholders' Equity | -7.86M | 1.99M | 12.87M | 36.90M | 47.40M | |||
| TOTAL LIABILITIES AND EQUITY | 10.14M | 36.63M | 57.92M | 108.00M | 124.20M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 4.83 | 1.90 | 0.79 | N/A | |||
| Current Ratio | 0.26 | 1.50 | 6.36 | 21.02 | 46.00 | |||
| Return On Assets (ROA) | -279.27% | -81.94% | -58.65% | -28.32% | -6.71% | |||
| Return On Equity (ROE) | N/A | -1506.93% | -264.03% | -82.90% | -17.57% | |||
All data in USD , ROIC based on taxRate of 0.21